Retinoblastoma regression following intra-arterial chemotherapy to the contralateral eye
Intra-arterial chemotherapy (IAC) has assumed a major role in the management of retinoblastoma. This targeted therapy involves the delivery of chemotherapy directly into the ophthalmic artery, minimizing systemic absorption. We report a case of retinoblastoma regression in the untreated eye followin...
Main Authors: | Grace L. Su, Li-Anne S. Lim, R. Joel Welch, Carol L. Shields |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-07-01
|
Series: | Saudi Journal of Ophthalmology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1319453419300360 |
Similar Items
-
Update on Intra-Arterial Chemotherapy for Retinoblastoma
by: Mario Zanaty, et al.
Published: (2014-01-01) -
Parafoveolar retinoblastoma regression with foveal preservation following intra-arterial chemotherapy documented on hand-held optical coherence tomography in a newborn
by: Vera Yarovaya, et al.
Published: (2017-11-01) -
Intra-arterial chemotherapy in retinoblastoma – A paradigm change
by: Fairooz P Manjandavida, et al.
Published: (2019-01-01) -
Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras
by: Evan B Selzer, et al.
Published: (2019-01-01) -
Intra-arterial chemotherapy for retinoblastoma
by: Jorge Balderrama, et al.
Published: (2013-12-01)